Description for individual tablet identification to enforce from 2005.

Published: 2003-12-08 06:59:00

Updated: 2003-12-08 06:59:00

For the prevention of any possible misuse of drugs, the KFDA is considering to adopt a provision of which an individual unit of oral solid formed drugs should be marked with an identification description taking effect from 2005.

The KFDA already instructed for the Korea Pharmacy Information F...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK